Ling Huang
Ningbo, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Research progress on the neural mechanism of light therapy improving cognitive function in depression: from retinal projections to neuroplasticity.
Journal: Frontiers in neurology
Published: December 16, 2025
Efficacy of hyperbaric oxygen therapy for post-stroke depression: Association with inflammatory biomarker reduction in a sham-controlled randomized trial.
Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
Published: October 28, 2025
Hyperbaric Oxygen Therapy Upregulates Neurotrophic Factors to Ameliorate Post-Stroke Depression: A Randomized Sham-Controlled Trial.
Journal: Neuropsychiatric disease and treatment
Published: October 13, 2025
A Multi-Label Deep Learning Model for Detailed Classification of Alzheimer's Disease.
Journal: Actas espanolas de psiquiatria
Published: January 13, 2025
Decreased prefrontal activation during verbal fluency task after repetitive transcranial magnetic stimulation treatment for depression in Alzheimer's disease: a functional near-infrared spectroscopy study.
Journal: Frontiers in aging neuroscience
Published: July 07, 2024
Fucoxanthin, a marine derived carotenoid, attenuates surgery-induced cognitive impairments via activating Akt and ERK pathways in aged mice.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: March 20, 2023
Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVID-19 pandemic.
Journal: Frontiers in psychiatry
Published: August 11, 2022
Association of human serotonin receptor 4 promoter methylation with autism spectrum disorder.
Journal: Medicine
Published: January 25, 2020
Tacrine(10)-hupyridone, a dual-binding acetylcholinesterase inhibitor, potently attenuates scopolamine-induced impairments of cognition in mice.
Journal: Metabolic brain disease
Published: August 09, 2017
Sunitinib, a Clinically Used Anticancer Drug, Is a Potent AChE Inhibitor and Attenuates Cognitive Impairments in Mice.
Journal: ACS chemical neuroscience
Published: April 06, 2016
Fucoxanthin, a Marine Carotenoid, Reverses Scopolamine-Induced Cognitive Impairments in Mice and Inhibits Acetylcholinesterase in Vitro.
Journal: Marine drugs
Published: January 07, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026